<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4--><!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
   <PublisherInfo>
      <PublisherName>Springer-Verlag</PublisherName>
      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
   </PublisherInfo>
   <Journal>
      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">
         <JournalID>401</JournalID>
         <JournalPrintISSN>0001-6322</JournalPrintISSN>
         <JournalElectronicISSN>1432-0533</JournalElectronicISSN>
         <JournalSPIN/>
         <JournalTitle>Acta Neuropathologica</JournalTitle>
         <JournalSubTitle/>
         <JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Legacy</JournalSubject>
</JournalSubjectGroup>
      </JournalInfo>
      <Volume>
         <VolumeInfo VolumeType="Regular">
<VolumeIDStart>101</VolumeIDStart>
<VolumeIDEnd>101</VolumeIDEnd>
<VolumeIssueCount/>
</VolumeInfo>
         <Issue IssueType="Regular">
            <IssueInfo TocLevels="0">
               <IssueIDStart>2</IssueIDStart>
               <IssueIDEnd>2</IssueIDEnd>
               <IssueHistory>
                  <OnlineDate>
                     <Year>2000</Year>
                     <Month>11</Month>
                     <Day>30</Day>
                  </OnlineDate>
                  <PrintDate>
                     <Year>2001</Year>
                     <Month>2</Month>
                     <Day/>
                  </PrintDate>
                  <CoverDate>
                     <Year>2001</Year>
                     <Month>2</Month>
                  </CoverDate>
               </IssueHistory>
               <IssueCopyright>
                  <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                  <CopyrightYear>2000</CopyrightYear>
               </IssueCopyright>
            </IssueInfo>
            <Article ID="Art1">
               <ArticleInfo ArticleType="BriefCommunication" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
                  <ArticleID>00312</ArticleID>
                  <ArticleDOI>10.1007/s004010000312</ArticleDOI>
                  <ArticleTitle Language="En">Autoradiography with [<Superscript>3</Superscript>H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis</ArticleTitle>
                  <ArticleCategory>Express Communication</ArticleCategory>
                  <ArticleFirstPage>75</ArticleFirstPage>
                  <ArticleLastPage>78</ArticleLastPage>
                  <ArticleHistory>
                     <Received>
                        <Year>2000</Year>
                        <Month>06</Month>
                        <Day>26</Day>
                     </Received>
                     <Revised>
                        <Year>2000</Year>
                        <Month>09</Month>
                        <Day>21</Day>
                     </Revised>
                     <Accepted>
                        <Year>2000</Year>
                        <Month>09</Month>
                        <Day>25</Day>
                     </Accepted>
                  </ArticleHistory>
                  <ArticleCopyright>
                     <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                     <CopyrightYear>2000</CopyrightYear>
                  </ArticleCopyright>
<ArticleGrants>
<MetadataGrant Grant="OpenAccess"/>
<AbstractGrant Grant="OpenAccess"/>
<BodyPDFGrant Grant="Restricted"/>
<BodyHTMLGrant Grant="Restricted"/>
<BibliographyGrant Grant="Restricted"/>
<ESMGrant Grant="Restricted"/>
</ArticleGrants>
               </ArticleInfo>
               <ArticleHeader>
                  <AuthorGroup>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>H. H.</GivenName>
                           <FamilyName>Sitte</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A2">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>J.</GivenName>
                           <FamilyName>Wanschitz</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A2">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>H.</GivenName>
                           <FamilyName>Budka</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>M. L.</GivenName>
                           <FamilyName>Berger</FamilyName>
                        </AuthorName>
                        <Contact>
                           <Phone>+43-1-427762892</Phone>
                           <Fax>+43-1-427762899</Fax>
                           <Email>michael.berger@univie.ac.at</Email>
                        </Contact>
                     </Author>
                     <Affiliation ID="A1">
                        <OrgName>Institute of Biochemical Pharmacology, University of Vienna, Vienna, Austria</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A2">
                        <OrgName>Institute of Neurology, AKH, Vienna, Austria</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A3">
                        <OrgName>Present address: Brain Research Institute, University of Vienna, Div. Molecular Neurobiology, Spitalgasse 4, 1090 Vienna, Austria</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A4">
                        <OrgName>Present address: Institute of Pharmacology, University of Vienna, Austria</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                  </AuthorGroup>
                  <Abstract ID="Abs1" Language="En">
                     <Heading>Abstract.</Heading>
                     <Para> The diagnostic hallmarks of amyotrophic lateral sclerosis (ALS) are degeneration of upper and lower motor neurons and of corticospinal tracts. Here, we demonstrate the suitability of the gliosis marker [<Superscript>3</Superscript>H]PK11195 for quantitative evaluation of tract degeneration in ALS in vitro. Binding of [<Superscript>3</Superscript>H]PK11195 was increased in lateral and ventral white matter of ALS spinal cords but not in the anterior horn, in spite of a dramatic loss in muscarinic binding sites and a high level of oxidatively modified protein. Labeling of activated microglia with [<Superscript>11</Superscript>C]PK11195 may also allow tract degeneration in ALS to be visualized in vivo.</Para>
                  </Abstract>
                  <KeywordGroup Language="En">
                     <Keyword>Amyotrophic lateral sclerosis Peripheral benzodiazepine receptor Activated microglia</Keyword>
                  </KeywordGroup>
                  <ArticleNote Type="Misc">
                     <SimplePara>Electronic Publication</SimplePara>
                  </ArticleNote>
               </ArticleHeader>
               <BodyRef FileRef="BodyRef/PDF/401_2001_Article_312.pdf" TargetType="PDF"/>
            </Article>
         </Issue>
      </Volume>
   </Journal>
</Publisher>